Production (Stage)
CorMedix Inc.
CRMD
$12.36
$0.100.82%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 134.20% | 61.31% | -15.97% | -43.93% | -51.16% |
| Total Depreciation and Amortization | 494.32% | 337.57% | 161.13% | 73.11% | -6.89% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 27.67% | 13.96% | 19.21% | 15.38% | 11.10% |
| Change in Net Operating Assets | -3,681.25% | -1,866.88% | -2,701.31% | -965.27% | -705.43% |
| Cash from Operations | 70.07% | -31.78% | -64.84% | -63.24% | -61.84% |
| Capital Expenditure | 82.69% | 64.62% | -150.81% | -77.65% | -62.59% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 75.05% | 227.56% | 228.76% | 192.13% | 149.67% |
| Cash from Investing | 84.03% | 224.43% | 225.32% | 188.57% | 146.24% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -31.06% | -52.58% | -74.49% | 131.71% | 121.39% |
| Repurchase of Common Stock | -309.98% | -45.97% | -19.25% | -19.25% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -33.14% | -52.93% | -74.79% | 132.88% | 120.05% |
| Foreign Exchange rate Adjustments | -133.33% | -160.71% | -88.27% | -108.11% | 90.63% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 214.62% | -783.99% | -280.54% | 129.92% | 149.01% |